This grant, offered by the Molecular Atlas of Lung Development Program (LungMAP), aims to establish a comprehensive molecular and cellular atlas of the human lung, specifically focusing on its Human Tissue Core. The primary objective is to create an invaluable reference platform to deepen the understanding of both normal lung biology and complex disease pathobiology. This initiative will be instrumental in identifying critical cellular components, key molecular pathways, and novel therapeutic targets for various lung diseases. LungMAP is envisioned as an accessible, open-source resource, meticulously integrating multi-scale, high-content, and high-resolution information. This data will precisely define lung cells based on their gene expression profiles, physiological states, three-dimensional locations, and their developmental and pathological trajectories within the human lung.
Opportunity ID: 350110
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HL-24-015 |
| Funding Opportunity Title: | Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 – Human Tissue Core (U01- Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.838 — Lung Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 06, 2023 |
| Last Updated Date: | Sep 06, 2023 |
| Original Closing Date for Applications: | Oct 27, 2023 |
| Current Closing Date for Applications: | Oct 27, 2023 |
| Archive Date: | Dec 02, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $300,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See full Notice of Funding Opportunity for additional details on eligibility. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The objective of the Molecular Atlas of Lung Development (LungMAP) program is to build a comprehensive molecular and cellular atlas of the human lung to serve as a reference platform to better understand both normal biology and disease pathobiology, and to identify critical cellular components, molecular pathways, and novel therapeutic targets in lung disease. LungMAP is an open access resource integrating multi-scale, high-content, high-resolution information to define lung cells with gene expression, physiological states, 3-dimensional locations, as well as developmental and pathological trajectories. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-24-015.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 350110 Full Announcement-RFA-HL-24-015 -> RFA-HL-24-015-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00283074 | Sep 27, 2023 | Oct 27, 2023 | View |
Package 1
Mandatory forms
350110 RR_SF424_5_0-5.0.pdf
350110 PHS398_CoverPageSupplement_5_0-5.0.pdf
350110 RR_OtherProjectInfo_1_4-1.4.pdf
350110 PerformanceSite_4_0-4.0.pdf
350110 RR_KeyPersonExpanded_4_0-4.0.pdf
350110 PHS398_ResearchPlan_5_0-5.0.pdf
350110 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
350110 RR_Budget_3_0-3.0.pdf
350110 RR_SubawardBudget30_3_0-3.0.pdf
350110 PHS398_ModularBudget_1_2-1.2.pdf
350110 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
